Gilead Sciences, a privately owned company headquartered in the US, was founded in 1987. With approximately 13,690 employees, the company functions as a tier 1 media tech buyer. Gilead Sciences specializes in biotechnology research, focusing on bringing forward medicines for life-threatening diseases. The company's operations involve its employees collaborating through science to address medical challenges.
On September 10, Gilead Sciences' Associate Director of US Compliance Monitoring, Jamie Lutz, spoke at the Transparency & HCP Engagement conference in Philadelphia, sharing insights on speaker program oversight that prioritizes relationship-building alongside regulatory rigor. Earlier on September 10, Andrew Dickinson, Executive Vice President and Chief Financial Officer, presented at the 12th Annual Cantor Fitzgerald Global Healthcare Conference. Also on September 10, Gilead celebrated the opening of its 182,000-square-foot Research Center at its Foster City headquarters, expanding capabilities in oncology, inflammation, and research data science to accelerate drug discovery for challenging diseases.
Similar Companies
Subscribe for full access to Gilead Sciences's profile
Gilead Sciences offers 2 products in the media and telecoms services industry. Gilead Sciences's product portfolio comprises of search, social, and retail media.
Subscribe for full access to Gilead Sciences's products in full detail
Subscribe for full access to Gilead Sciences's revenue in full detail
Subscribe for full access to Gilead Sciences's products in full detail 
